SuperX
  1. Home
  2. Stocks
  3. MACTER
  4. News and notes

MACTER · PHARMACEUTICALS

MACTER news and notes Macter International Limited

Macter International Limited (MACTER) news and notes: the SuperX note, what changed (4 items) and 1 news story. The note is written by SuperX’s AI from its own figures. What changed is listed newest first. Headlines are the publishers’ own words, linked to them.

What SuperX wrote about MACTER

  1. The price rose 1.68% on 20 Nov, with volume at 0.32 times the usual level. The sector median was flat that day.

  2. Last year the company filed its half-year results on 16 Feb. The half-year period ends 31 Dec.

  3. The price fell 5.93% in the past week. The 1-year return is -28.25%. The price is above its 50-day average but below its 200-day average.

Written by SuperX’s analyst desk from SuperX’s own figures, from the close of 20 Nov 2026. Each number was checked against those figures. Not advice.

What changed for MACTER, newest first

  • 20 Nov 2026Closed 49.67, +1.68%. Volume 20,223, 0.4 times the average of the 30 sessions before it, 46,570.
  • 17 Nov 2026Trend read changed to sideways: above the 50-day average, below the 200-day; roughly flat over 3 months (−10.0%).
  • 22 Oct 2026Quarter ended 30 Sep 2026: earnings per share Rs 0.43, sales Rs 3.1 bn, down 36.7% on the same quarter a year before. Earnings per share restated for the split of 16 Nov 2026, filed 2.16.
  • NextHalf-year results (to 31 Dec 2026) expected 1 Feb 2027 – 13 Mar 2027, a projection. An estimate from the dates of the last 8 filings.

As of the close of 20 Nov 2026. Closes and notices: PSX. Trend read: SuperX, from daily closes. Volume: against the average of the 30 sessions before the last. Next results: an estimate from the dates of the last 8 filings. Not advice.

News about MACTER

From 23 Sep 2026 to 23 Sep 2026. A story is listed here when its headline names the company and names three companies or fewer. Headlines are the publishers’ own words and link to them.

More on MACTER

Data from PSX via SuperX, delayed and provided for information only — not investment advice. Figures may contain errors; verify with your broker before acting. As of .